Investigation of the Mechanism of Clearance of AMG 386, a Selective Angiopoietin-1/2 Neutralizing Peptibody, in Splenectomized, Nephrectomized, and FcRn Knockout Rodent Models
Benjamin Wu(Amgen (United States)), Yu‐Nien Sun(Janssen (United States)), Manuel Antonio Díaz de León Ponce(Amgen (United States)), Marcus Soto(Amgen (United States)), Dominador Calamba(Amgen (United States)), Jessica Johnson(University of North Carolina at Chapel Hill)
Cited by 15
Related Papers
De novo mutations in schizophrenia implicate synaptic networks
|Nature|2014|1.7k
Gene expression elucidates functional impact of polygenic risk for schizophrenia
|Nature Neuroscience|2016|1.2k
Regulation of tradeoffs between plant defenses against pathogens with different lifestyles
|Proceedings of the National Academy of Sciences|2007|735
Genomic and epigenetic evidence for oxytocin receptor deficiency in autism
|BMC Medicine|2009|580